CLEERLY is a software that uses artificial intelligence to analyze coronary angiography images.
The benefits of using CLEERLY for prevention include:
Faster and more accurate diagnosis: The software can quickly and accurately identify areas of stenosis (narrowing) in the coronary arteries, which can help doctors make a diagnosis and plan treatment more quickly.
Improved patient outcomes: By using CLEERLY to analyze coronary angiography images, doctors can make more informed decisions about treatment, which can lead to better patient outcomes.
Increased efficiency: The software can analyze images in a fraction of the time it would take a human to do the same, which can help increase efficiency in the diagnostic process.
Reduced human error: By automating the analysis of coronary angiography images, CLEERLY can help reduce the potential for human error, which can improve the accuracy of diagnoses.
Cost-effective: By reducing the time and resources needed to analyze images and improving the accuracy of diagnoses, CLEERLY can help reduce costs for healthcare providers.
of people who will suffer a heart attack - the most common cause of death in both men and women - will do so without experiencing any prior symptoms. 1
of heart attack victims are considered low risk by traditional clinical scoring. 2
of lesions that are responsible for heart attacks cause only mild narrowing of the arteries and are missed by conventional stress testing. 3
The #1 Killer is Silent
Source: 1. Benjamin EJ et al. Circulation 2019; 2. Akosah KO et al. J. Am Coll Cardiol 2003; 3. Chang HJ et al. J Am Coll Caridol 2018
Finds the High-Risk Patients that Calcium Scoring Misses
The coronary artery calcium (CAC) scan can detect and quantify atherosclerosis and is valuable in informing treatment decisions in asymptomatic adults. However, it cannot detect and quantify low-density, non-calcified plaque, which is more likely than hardened and calcified plaque to rupture and cause a blood clot to form. Simply put, a CAC score of zero does not exclude the presence of high-risk plaque.
Cleerly’s model of personalized cardiovascular care leverages our AI-enabled analysis of coronary computed tomography angiography (CCTA) images to identify, characterize, and quantify plaque buildup. Several studies have concluded that CCTA shows coronary atherosclerosis in 41% to 53% of patients with a CAC score of zero. The Western Denmark Health Study further found that 31% of major adverse cardiac events occur in patients with a
CAC score of zero.
The healthcare system misses more than half of patients who appear to be the picture of health but suffer a heart attack because they have a buildup of non-calcified plaque that a traditional CAC scan misses. Cleerly identifies patients at a high risk of coronary artery disease sooner than the traditional CAC scan. This can help physicians prevent heart attacks – and reduce the number of preventable but costly hospitalizations and readmissions that healthcare
organizations experience every year.
The costs involved with having a preventative CLEERLY Angiogram is $2100. Screening comprehensive blood work for cardiovascular risk factors averages about $350.